Ginko Biloba Isn't Just Brain Food

New research from Brigham and Women's Hospital in Boston was recently presented to the American Association for Cancer Research concluding that women who took Ginko Biloba supplements for at least 6 months were 60% less likely to have ovarian cancer. In this study, 600 women with ovarian cancer were compared with 640 women who were healthy. Positive results were found as specific compounds in Ginko Biloba called ginkgolides, were tested on ovarian cancer cells. Thought the exact dosage used by the women was not revealed in the study, the usual dose is 60 to 120 mg. a day. Continued research is needed before any cancer prevention claims can be made on Ginko Biloba's behalf, but the findings thus far are quite significant.